API

Ziprasidone (40mg)

Drug classification

Antipsychotics (atypical antipsychotic)

Dosage form

Capsule

API strength per dosage

40 mg

Dose

Mechanism of action

Antagonizes dopamine D2 and serotonin 5-HT2A receptors, inhibits serotonin 5-HT1D and 5-HT2C receptors, partially agonizes 5-HT1A receptors, and inhibits norepinephrine and serotonin reuptake, resulting in antipsychotic, antidepressant, and anxiolytic effects.

Indications

Schizophrenia Mania

Side effects

Headache Nausea Vomiting Sleepiness Abnormal vision Dystonia involuntary muscle contractions Akathisia inability to stay still Weakness Parkinsonism Dizziness Respiratory tract infection

Pregnancy category

Precautions

Contraindications